about
T cell avidity and tumor recognition: implications and therapeutic strategies.Tumor-associated antigens as possible targets for immune therapy in head and neck cancer: comparative mRNA expression analysis of RAGE and GAGE genesProgress on new vaccine strategies for the immunotherapy and prevention of cancer.Immunological weapons against acute myeloid leukaemia.Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical studyTherapeutic vaccination with tumor cells that engage CD137.Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?Clinical application of dendritic cells in cancer vaccination therapy.Dendritic cell therapy for skin cancer.Influence of immunotherapy with autologous dendritic cells on innate and adaptive immune response in cancer.Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.Multigene RNA vector based on coronavirus transcription.Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes.A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells.Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy.SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma.The first 1000 dendritic cell vaccinees.
P2860
Q24815775-3358C646-51CA-49A9-A14C-FF8B3F11A3D6Q28219945-CEEE72A3-8E76-4BE0-83A3-9A3D0176703FQ34328457-75017F1B-5AF5-48CE-A6E4-4DE84FDF1023Q34842175-0678C656-639A-4013-84A6-15E6F2CE1C3EQ35011097-2C2B4E33-5027-4F11-9E83-64A1CB88E1B3Q35071688-2C37CD1F-C4EF-4ACB-B31B-AD596A16042BQ35142329-500E5393-2530-4491-AC9B-39A5E0E888E2Q35219339-645CC7EC-2952-46D5-A4B1-D4703380B56DQ35812979-21E44813-7E21-4338-B92D-70DD11E58358Q37070898-6DBDA713-CE4D-429B-91FA-618D5D9873FBQ39104547-1E685F54-1A66-4156-A76B-6E55A98B848DQ39996428-B4A43EC8-DA47-4C24-AA7C-EC7989F336ABQ40600872-7EAA58AB-9DE8-4FD7-B0A1-61868131B930Q40605843-E892A8B2-8EC5-4E4B-96EF-E74F7E8FFEBCQ47449736-CB1E7303-3CF5-4864-9FDA-711E645F7E3AQ48161285-22F2CCC4-17E4-4BCA-BEB5-7C8525D4B6E9Q50736412-5C5FAB9C-ED37-4C88-B711-DCF96D469523
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Dendritic cell vaccination for cancer therapy.
@ast
Dendritic cell vaccination for cancer therapy.
@en
Dendritic cell vaccination for cancer therapy.
@nl
type
label
Dendritic cell vaccination for cancer therapy.
@ast
Dendritic cell vaccination for cancer therapy.
@en
Dendritic cell vaccination for cancer therapy.
@nl
prefLabel
Dendritic cell vaccination for cancer therapy.
@ast
Dendritic cell vaccination for cancer therapy.
@en
Dendritic cell vaccination for cancer therapy.
@nl
P2860
P356
P1433
P1476
Dendritic cell vaccination for cancer therapy.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204095
P407
P577
2000-12-01T00:00:00Z
P5875
P6179
1006004604